Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 227
of 12Next
1:

Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus.

Pedotti R, Sanna M, Tsai M, DeVoss J, Steinman L, McDevitt H, Galli SJ.

BMC Immunol. 2003 Feb 22;4:2. Epub 2003 Feb 22.

PMID: 12597780 [PubMed - indexed for MEDLINE]

2:

Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.

Saï P, Rivereau AS, Granier C, Haertlé T, Martignat L.

Clin Exp Immunol. 1996 Aug;105(2):330-7.

PMID: 8706342 [PubMed - indexed for MEDLINE]

4:

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL.

J Exp Med. 1996 Apr 1;183(4):1561-7.

PMID: 8666914 [PubMed - indexed for MEDLINE]

5:

MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.

Quinn A, McInerney MF, Sercarz EE.

J Immunol. 2001 Aug 1;167(3):1748-57.

PMID: 11466400 [PubMed - indexed for MEDLINE]

6:

Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.

Boyton RJ, Lohmann T, Londei M, Kalbacher H, Halder T, Frater AJ, Douek DC, Leslie DG, Flavell RA, Altmann DM.

Int Immunol. 1998 Dec;10(12):1765-76.

PMID: 9885897 [PubMed - indexed for MEDLINE]

7:

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

Maron R, Melican NS, Weiner HL.

J Autoimmun. 1999 Jun;12(4):251-8.

PMID: 10330296 [PubMed - indexed for MEDLINE]

8:

Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).

Han G, Li Y, Wang J, Wang R, Chen G, Song L, Xu R, Yu M, Wu X, Qian J, Shen B.

J Immunol. 2005 Apr 15;174(8):4516-24.

PMID: 15814672 [PubMed - indexed for MEDLINE]

10:

T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).

Quinn A, Sercarz EE.

J Autoimmun. 1996 Jun;9(3):365-70.

PMID: 8816972 [PubMed - indexed for MEDLINE]

11:

Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.

PMID: 15381770 [PubMed - indexed for MEDLINE]

12:

Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.

Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B.

J Autoimmun. 1998 Dec;11(6):591-601.

PMID: 9878081 [PubMed - indexed for MEDLINE]

13:

Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.

Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.

Diabetologia. 2002 May;45(5):668-76. Epub 2002 Apr 4.

PMID: 12107747 [PubMed - indexed for MEDLINE]

14:

B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.

Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N.

J Immunol. 1998 Aug 1;161(3):1163-8.

PMID: 9686575 [PubMed - indexed for MEDLINE]

15:

Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.

Schloot NC, Daniel D, Norbury-Glaser M, Wegmann DR.

J Autoimmun. 1996 Jun;9(3):357-63.

PMID: 8816971 [PubMed - indexed for MEDLINE]

16:

Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Menard V, Jacobs H, Jun HS, Yoon JW, Kim SW.

Pharm Res. 1999 Jul;16(7):1059-66.

PMID: 10450931 [PubMed - indexed for MEDLINE]

17:

Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.

Chen SL, Whiteley PJ, Freed DC, Rothbard JB, Peterson LB, Wicker LS.

J Autoimmun. 1994 Oct;7(5):635-41.

PMID: 7840855 [PubMed - indexed for MEDLINE]

18:

Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

J Immunol. 2001 Mar 1;166(5):2982-91.

PMID: 11207247 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 227
of 12Next